[May 19, 2016]

Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C Pipeline Report, H1 2016 - Review of 5 Companies and Their Drug Profiles - Research and Markets

Research and Markets has announced the addition of the "Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to prduce first-in-class and best-in-class products.

Key Topics Covered:

1. Introduction
2. Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C Overview
3. Therapeutics Development
4. Pipeline Products for Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C - Overview
5. Pipeline Products for Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C - Comparative Analysis
6. Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C - Therapeutics under Development by Companies
7. Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C - Therapeutics under Investigation by Universities/Institutes
8. Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C Products Glance
9. Late Stage Products
10. Clinical Stage Products
11. Early Stage Products
12. Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C - Products under Development by Companies
13. Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C - Products under Investigation by Universities/Institutes
14. Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C - Companies Involved in Therapeutics Development

• CTD Holdings, Inc.
• La Jolla Pharmaceutical Company
• Merck & Co., Inc.
• Okklo Life Sciences BV
• Orphazyme ApS

For more information visit http://www.researchandmarkets.com/research/rr6q5m/acid

View source version on businesswire.com: http://www.businesswire.com/news/home/20160519005537/en/

[ Back To TMCnet.com's Homepage ]